STOCKSCOUTER

StockScouter Premium

StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance

IDXG INTERPACE BIOSCIENCES INCORPORATED StockScouter® Report

3

StockScouter® Score

INTERPACE BIOSCIENCES INCORPORATED, a micro cap value company in the healthcare sector, is expected to underperform the market over the next six months with higher than average risk

10 is the best possible rating. Learn more.

Summary

Positives

  • The enterprise value-to-sales ratio is approximately in line with that of comparably-sized companies in the StockScouter universe. Neutral

 

Concerns

  • The 50-day moving average for IDXG is significantly below its 200-day moving average. Negative
  • Earnings growth in the past year has decelerated moderately compared to earnings growth in the past three years. Negative
  • The multi-period measure of relative price change and consistency is below average. Negative/Neutral

 

Short-term Outlook

Over the next 1-2 months, StockScouter forecasts that micro cap stocks will be neutral, value stocks will be neutral, and healthcare stocks will be neutral.

Expected Risk/Return

Progress: 100% done.
Progress: 20% done.
Low
High

Core Model Grades

D
N/A
C
F

Previous Ratings